We and others have shown that our compounds display impressive efficacy in animal models for many human diseases.

Our single-minded focus now is with our partner to reach clinical trials with our drug candidate in neurodegenerative diseases:

Ataxia Telangiectasia		www.atcp.org
Friedreich ataxia		www.curefa.org
Other (undisclosed)